A statement of changes in beneficial ownership for Nutex Health Inc. ( Nasdaq : NUTX) was filed by director Cheryl Yvonne Grenas on August 3, 2026, reflecting a transaction dated July 31, 2026.

Key Highlights

  • Reporting person: Cheryl Yvonne Grenas, identified as a Director of Nutex Health Inc.
  • Transaction date: July 31, 2026, with the filing signed and submitted on August 3, 2026.
  • Securities acquired: 603 shares of common stock acquired via transaction code M at a price of $0.
  • Resulting ownership: 670 shares of common stock held directly following the reported transaction.
  • Conversion basis: According to the filing, the restricted stock units convert into common stock on a one-for-one basis.

Nutex Health Director Cheryl Grenas Converts Restricted Stock Units Into Common Shares

According to the filing, Cheryl Yvonne Grenas, a Director of Nutex Health Inc., reported the Acquisition of 603 shares of common stock on July 31, 2026. The transaction was recorded under transaction code M, which the filing associates with the conversion of a derivative security. The price reported for the acquisition was $0, consistent with the filing's footnote explaining that restricted stock units convert into common stock on a one-for-one basis at no additional cost to the holder.

Nutex Health Inc., trading on NASDAQ under the ticker NUTX, is the issuer named in the disclosure. The filing was made individually by one reporting person and was not filed jointly. Following the reported conversion, Grenas is disclosed as directly holding 670 shares of common stock in total. No derivative securities remain listed in Table II of the filing, and no indirect ownership positions were reported.

The filing was submitted pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires directors, officers, and significant shareholders of publicly traded companies to disclose changes in their beneficial ownership. The document was signed by Cheryl Grenas on August 3, 2026. No amendment date was listed, indicating this is an original filing rather than a revision to a prior submission.

What Was Disclosed

The filing disclosed that director Cheryl Yvonne Grenas acquired 603 shares of Nutex Health Inc. common stock on July 31, 2026, through the conversion of restricted stock units at $0, resulting in a directly held position of 670 shares.